CN113455652A - Medicated food for treating gastric cancer and rectal cancer and preparation method thereof - Google Patents
Medicated food for treating gastric cancer and rectal cancer and preparation method thereof Download PDFInfo
- Publication number
- CN113455652A CN113455652A CN202110797506.XA CN202110797506A CN113455652A CN 113455652 A CN113455652 A CN 113455652A CN 202110797506 A CN202110797506 A CN 202110797506A CN 113455652 A CN113455652 A CN 113455652A
- Authority
- CN
- China
- Prior art keywords
- cancer
- gastric cancer
- loach
- rectal cancer
- treating gastric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000005718 Stomach Neoplasms Diseases 0.000 title claims abstract description 42
- 206010017758 gastric cancer Diseases 0.000 title claims abstract description 42
- 201000011549 stomach cancer Diseases 0.000 title claims abstract description 42
- 208000015634 Rectal Neoplasms Diseases 0.000 title claims abstract description 38
- 206010038038 rectal cancer Diseases 0.000 title claims abstract description 38
- 201000001275 rectum cancer Diseases 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 235000013305 food Nutrition 0.000 title claims description 6
- 241000252185 Cobitidae Species 0.000 claims abstract description 55
- 235000014347 soups Nutrition 0.000 claims abstract description 40
- 235000005911 diet Nutrition 0.000 claims abstract description 32
- 230000037213 diet Effects 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000011194 food seasoning agent Nutrition 0.000 claims abstract description 17
- 210000003097 mucus Anatomy 0.000 claims abstract description 12
- 210000001835 viscera Anatomy 0.000 claims abstract description 9
- 238000009835 boiling Methods 0.000 claims abstract description 8
- 238000001816 cooling Methods 0.000 claims abstract description 8
- 238000007667 floating Methods 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 6
- 208000007882 Gastritis Diseases 0.000 claims description 25
- 239000004278 EU approved seasoning Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 244000295724 Allium chinense Species 0.000 claims description 7
- 235000016790 Allium chinense Nutrition 0.000 claims description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 7
- 235000008397 ginger Nutrition 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 235000002639 sodium chloride Nutrition 0.000 claims description 7
- 235000021419 vinegar Nutrition 0.000 claims description 7
- 239000000052 vinegar Substances 0.000 claims description 7
- 206010006187 Breast cancer Diseases 0.000 claims description 6
- 208000026310 Breast neoplasm Diseases 0.000 claims description 6
- 206010025323 Lymphomas Diseases 0.000 claims description 6
- 241000234435 Lilium Species 0.000 claims description 5
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 5
- 208000032839 leukemia Diseases 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 201000005202 lung cancer Diseases 0.000 claims description 5
- 208000020816 lung neoplasm Diseases 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims 1
- 235000008216 herbs Nutrition 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 17
- 238000011282 treatment Methods 0.000 abstract description 16
- 210000004881 tumor cell Anatomy 0.000 abstract description 8
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000013508 migration Methods 0.000 abstract 1
- 230000005012 migration Effects 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 16
- 238000002512 chemotherapy Methods 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 241000234314 Zingiber Species 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000001959 radiotherapy Methods 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 235000006533 astragalus Nutrition 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000009401 metastasis Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 244000075634 Cyperus rotundus Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 2
- 229960001756 oxaliplatin Drugs 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000001179 synovial fluid Anatomy 0.000 description 2
- WFWLQNSHRPWKFK-ZCFIWIBFSA-N tegafur Chemical compound O=C1NC(=O)C(F)=CN1[C@@H]1OCCC1 WFWLQNSHRPWKFK-ZCFIWIBFSA-N 0.000 description 2
- 229960001674 tegafur Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 201000002327 urinary tract obstruction Diseases 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 244000150195 Cyperus longus Species 0.000 description 1
- 235000018109 Cyperus longus Nutrition 0.000 description 1
- 235000016854 Cyperus rotundus Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 244000116484 Inula helenium Species 0.000 description 1
- 235000002598 Inula helenium Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 244000272264 Saussurea lappa Species 0.000 description 1
- 235000006784 Saussurea lappa Nutrition 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 235000005010 Scirpus paludosus Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 201000011529 cardiovascular cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 238000002638 palliative care Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a medicated diet for treating gastric cancer and rectal cancer and a preparation method thereof, wherein the preparation method comprises the following steps: (1) taking 180g of wild loaches, scalding with 10-20 times of boiled water, and reserving the boiled water and mucus floating on the upper layer; (2) taking out viscera of loach, adding into the boiled water, adding 1-5g of seasoning, boiling with strong fire, stewing with slow fire for 30-45min, decocting loach to be thoroughly cooked, decocting the final soup with 800 plus materials in 1000ml, taking out loach residue, and cooling the soup to obtain the loach soup. The medicinal diet for treating the gastric cancer and the rectal cancer has the effects of inhibiting the growth and migration of tumor cells and promoting the apoptosis of the tumor cells, improves the curative effect of tumor treatment and improves the tumor prognosis effect.
Description
Technical Field
The invention relates to the technical field of gastric cancer treatment, and particularly relates to a medicated diet for treating gastric cancer and rectal cancer and a preparation method thereof.
Background
The gastric cancer is a malignant tumor originated from gastric mucosa epithelium, the incidence rate of the gastric cancer is the first in various malignant tumors in China, the incidence rate of the gastric cancer is obviously different regionally, and the incidence rate of the gastric cancer is obviously higher in northwest and east coastal areas of China than in south areas.
The traditional treatment method has various defects, the tumor can be removed by surgical treatment, however, the surgical risk is high, the wound of the operation on the human body is large, the immunity of a patient is reduced, the resistance to diseases is reduced, the operation is a local treatment means, and the traditional treatment method is only suitable for the patient with early stage and body condition tolerance; surgical resection cannot remove roots and can directly result in tumor cell spread.
The chemotherapy drugs are almost all cytotoxic drugs, and have certain toxic and side effects on normal cells of a human body while killing tumor cells, particularly on cells which are divided, proliferated and relatively fast, such as bone marrow hematopoietic cells, intestinal mucosa epithelial cells and the like. Chemotherapy shortens the survival time of patients and makes part of tumors insensitive to drugs, and chemotherapy cannot completely kill all tumor cells in vivo, and the tumor cells can relapse or metastasize within a certain time. Radiation therapy is often used as an adjuvant or palliative treatment. While tumor destruction is achieved by radiation therapy, normal tissue cells are damaged to some extent, and beyond this limit, irreversible damage to the tissue occurs, and radiation therapy may reduce the immunity of the body. The radiation dose is calculated by theory, which is difficult to conform to the reality, and only the tumor less than 2cm can be completely destroyed at one time.
Disclosure of Invention
Aiming at the technical defects, the invention aims to provide a medicated diet for treating gastric cancer and rectal cancer and a preparation method thereof, so as to solve the problems in the background technology.
In order to solve the technical problems, the invention adopts the following technical scheme:
one aspect of the invention provides a preparation method of a medicated diet for treating gastric cancer and rectal cancer, which comprises the following steps:
(1) taking 180g of wild loaches, scalding with 10-20 times of boiled water, and reserving the boiled water and mucus floating on the upper layer;
(2) taking out viscera of loach, adding into the boiled water, adding 1-5g of seasoning, boiling with strong fire, stewing with slow fire for 30-45min, decocting loach to be thoroughly cooked, decocting the final soup with 800 plus materials in 1000ml, taking out loach residue, and cooling the soup to obtain the loach soup.
Preferably, the soup obtained in step (2) is drunk twice in the morning and evening, and each time is 400-500 mL. Mild gastritis for 7 days, moderate gastritis for 15 days, and severe gastritis for 21 days.
Preferably, the seasonings comprise green Chinese onion, ginger, salt and edible vinegar.
Preferably, in the step (2), traditional Chinese medicines are added while seasonings are added, wherein the traditional Chinese medicines comprise 10g of astragalus membranaceus and 15g of lily.
Preferably, the traditional Chinese medicine also comprises 1g of nutgrass galingale rhizome and 1g of costus root.
Preferably, the decoction or the original formula is purified and prepared into granules, capsules, tablets, pills, oral liquid or injection.
Preferably, the invention also provides a medicated diet for treating gastric cancer and rectal cancer, which is prepared by adopting the preparation method of the medicated diet for treating gastric cancer and rectal cancer.
In another aspect of the invention, the invention provides the application of the medicated diet for treating gastric cancer and rectal cancer in the process of treating gastric cancer, gastritis, rectal cancer, lymphoma, breast cancer, leukemia and lung cancer.
The invention has the beneficial effects that:
1. according to the medicated diet for treating the gastric cancer and the rectal cancer and the preparation method thereof, the special medicinal value of the loach epidermal mucus is fully utilized, an experimental formula is screened by adopting a dialectical theory, the astragalus, the lily, the rhizoma cyperi and the elecampane are screened out, and the formed medicated diet for treating the gastric cancer and the rectal cancer is scientific and reasonable in proportion;
2. the invention can help the patients with advanced tumor to improve symptoms, relieve pain and improve the survival quality of the patients. Can also achieve the effect of prolonging the life of the patient and even possibly survival with tumor.
3. The medicine can be used for treating tumors such as gastric cancer, breast cancer, gastritis, rectal cancer, lymphoma, breast cancer, leukemia, lung cancer and the like, and has a remarkable curative effect. The invention has relatively low treatment cost which is far lower than that of western medicine, and has obvious effect.
4. The invention has the advantages of easily obtained raw materials, simple process, low cost and high efficiency, and is beneficial to pharmaceutical enterprises to carry out drug production and quality control; the product has low price and is easy to be accepted by patients.
5. Compared with the existing treatment method of adopting chemotherapy on tumors, the medicated diet for treating gastric cancer and rectal cancer provided by the invention can obviously reduce the pain of tumor patients, improve the immune function of the patients and prolong the life cycle;
6. the medicine is pure natural Chinese herbal medicine, has high effective components, high safety, low toxic and side effects, good tolerance of patients, quick absorption of the patients and quick drug effect;
4. the medicated diet for treating gastric cancer and rectal cancer provided by the invention can be prepared into various dosage forms, is convenient to take clinically and popularize on a large scale, and has relatively lower treatment cost compared with chemotherapy and radiotherapy.
Partial effects of the raw materials in the invention:
the loach synovial fluid is mucus secreted from skin of loach, and is mainly used for treating urinary obstruction, heat evil, carbuncle and swelling. The health-care food can be eaten by general people, is particularly suitable for people with weakness, deficiency-cold in spleen and stomach, malnutrition, weakness and night sweat of children, and is beneficial to growth and development; it is suitable for the elderly, patients with cardiovascular diseases and cancer, patients with radiotherapy and chemotherapy, acute and chronic hepatitis and jaundice, especially acute jaundice hepatitis, and can promote jaundice and transaminase reduction; it is also suitable for people with sexual impotence, hemorrhoid, scabies, tinea and pruritus. The Misgurni Anguillicaudati has effects of invigorating spleen and replenishing qi, eliminating dampness and eliminating jaundice, invigorating kidney and tonifying yang, eliminating dampness and relieving diarrhea, warming spleen and stomach, treating hemorrhoid, and relieving asthenic perspiration. Loach contains various nutrients, proteins, saccharides, minerals (calcium, phosphorus and iron) and vitamins (VB, VA and VC) which are higher than those of common fishes and shrimps, has lower fat content and less cholesterol, contains unsaturated fat, and is cool in nature and best in summer.
The mucus on the body of the loach is called as loach synovial fluid in clinical application, has special medicinal value and is used for treating symptoms such as urinary obstruction, sore, furuncle, carbuncle and swelling; loach contains Siherocin protein capable of strengthening essence, and has the effects of strengthening kidney and tonifying yang after being eaten frequently; the loach also has certain curative effect of reducing transaminase and preventing and treating hepatitis by pharmacology. The mucus on loach is sweet in taste and cold in nature, and has the effects of clearing heat and removing toxicity, treating stranguria and the like.
Bulbus Lilii and Bulbus Lilii have effects of nourishing yin, clearing lung-heat, clearing heart fire and tranquilizing mind, and are mainly used for treating chronic cough due to yin deficiency, blood in phlegm, and persistent residual heat in late stage of fever, or symptoms of vexation, pavor, insomnia, dreaminess, absentmindedness, carbuncle swelling, eczema, etc.
Huang Qi is sweet and warm. Enter lung and spleen meridians. The efficacy is as follows: tonify middle-jiao and Qi. The main treatment is as follows: internal injury, overstrain, diarrhea due to spleen deficiency, rectocele, qi deficiency, blood collapse, and all syndromes due to qi deficiency and blood deficiency.
Cyperus rotundus, pungent, slightly bitter and sweet and neutral. Enter liver and triple energizer meridians. Has the effects of regulating qi, resolving stagnation, relieving pain and regulating menstruation. The main treatment is as follows: liver cirrhosis with disharmony in the stomach, qi stagnation, distending pain in the chest, abdomen and hypochondriac area, phlegm and fluid retention, menoxenia, metrorrhagia, metrostaxis and leukorrhagia.
Mu Xiang is warm in nature and pungent and bitter in flavor. It enters spleen, stomach, large intestine, triple energizer and gallbladder meridians. The efficacy is as follows: move qi and alleviate pain, invigorate spleen and promote digestion. It can be used for treating chest and abdominal pain, dysentery, diarrhea, dyspepsia, and anorexia.
Detailed Description
Example 1
A preparation method of a medicated diet for treating gastric cancer and rectal cancer comprises the following steps:
(1) taking 180g of wild loaches, scalding with 10 times of boiled water, and reserving the boiled water and mucus floating on the upper layer;
(2) taking out viscera of loach, adding into the boiled water, adding 1g of seasoning, boiling with strong fire, stewing with slow fire for 30min, decocting loach to be thoroughly cooked, finally decocting 800-1000ml of loach soup, taking out loach residues, and cooling the soup to obtain the loach soup.
When the soup obtained in the step (2) is used, the soup is drunk twice, once in the morning and at night, and 500mL of the soup is drunk every time. Mild gastritis for 7 days, moderate gastritis for 15 days, and severe gastritis for 21 days.
The seasonings comprise green Chinese onion, ginger, salt and edible vinegar.
Example 2
A preparation method of a medicated diet for treating gastric cancer and rectal cancer comprises the following steps:
(1) taking 180g of wild loaches, scalding with 20 times of boiled water, and reserving the boiled water and mucus floating on the upper layer;
(2) taking out viscera of loach, adding into the boiled water, adding 5g of seasoning, boiling with strong fire, stewing with slow fire for 45min, decocting loach to be thoroughly cooked, finally decocting 800-1000ml of loach soup, taking out loach residues, and cooling the soup to obtain the loach soup.
When the soup obtained in the step (2) is used, the soup is drunk twice, once in the morning and at night, and 500mL of the soup is drunk every time. Mild gastritis for 7 days, moderate gastritis for 15 days, and severe gastritis for 21 days.
The seasonings comprise green Chinese onion, ginger, salt and edible vinegar.
Example 3
A preparation method of a medicated diet for treating gastric cancer and rectal cancer comprises the following steps:
(1) taking 180g of wild loaches, scalding with 15 times of boiled water, and reserving the boiled water and mucus floating on the upper layer;
(2) taking out viscera of loach, adding into the boiled water, adding 3g of seasoning, boiling with strong fire, stewing with slow fire for 40min, decocting loach to be thoroughly cooked, finally decocting 800-1000ml of loach soup, taking out loach residues, and cooling the soup to obtain the loach soup.
When the soup obtained in the step (2) is used, the soup is drunk twice, once in the morning and at night, and 500mL of the soup is drunk every time. Mild gastritis for 7 days, moderate gastritis for 15 days, and severe gastritis for 21 days.
The seasonings comprise green Chinese onion, ginger, salt and edible vinegar.
Example 4
A preparation method of a medicated diet for treating gastric cancer and rectal cancer comprises the following steps:
(1) taking 180g of wild loaches, scalding with 15 times of boiled water, and reserving the boiled water and mucus floating on the upper layer;
(2) taking out internal organs of the loaches, adding the loaches into the boiled water, adding 3g of seasonings, 10g of astragalus membranaceus and 15g of lily, boiling the loaches with strong fire, stewing the loaches with slow fire for 30min, finally decocting 800 plus materials in the soup for 1000ml, fishing out loach residues, and cooling the soup to obtain the loach soup.
When the soup obtained in the step (2) is used, the soup is drunk twice, once in the morning and at night, and 500mL of the soup is drunk every time. Mild gastritis for 7 days, moderate gastritis for 15 days, and severe gastritis for 21 days.
The seasonings comprise green Chinese onion, ginger, salt and edible vinegar.
Example 5
A preparation method of a medicated diet for treating gastric cancer and rectal cancer comprises the following steps:
(1) taking 180g of wild loaches, scalding with 15 times of boiled water, and reserving the boiled water and mucus floating on the upper layer;
(2) taking loaches out viscera, adding into the boiled water, adding 3g of seasonings, 10g of radix astragali, 15g of lily, 1g of rhizoma cyperi and 1g of radix aucklandiae, boiling with strong fire, stewing with slow fire for 45min, decocting loaches to be thoroughly cooked, finally decocting soup into 800 plus materials for 1000ml, fishing out loach residues, and cooling the soup to obtain the loach viscera-containing soup.
When the soup obtained in the step (2) is used, the soup is drunk twice, once in the morning and at night, and 500mL of the soup is drunk every time. Mild gastritis for 7 days, moderate gastritis for 15 days, and severe gastritis for 21 days.
The seasonings comprise green Chinese onion, ginger, salt and edible vinegar.
The decoctions or formulations of examples 1-5 were purified and prepared into various dosage forms. For example, the decocted liquid medicine is sterilized and disinfected and then packaged to prepare oral liquid; or concentrating the decoction, oven drying, adding pharmaceutically acceptable adjuvants, and making into tablet, capsule, pill, etc.
The medically acceptable auxiliary materials comprise starch, dextrin, sodium carboxymethylcellulose, polyethylene glycol, calcium hydrogen phosphate, sodium alginate, potassium sorbate and the like, and can also be prepared into granules, capsules, tablets, pills, oral liquid or injection.
Example 6
A medicated diet for treating gastric cancer and rectal cancer is prepared by the preparation method of the medicated diet for treating gastric cancer and rectal cancer described in embodiments 1-5.
Example 7
The medicated diet for treating gastric cancer and rectal cancer is used for treating gastric cancer, gastritis, rectal cancer, lymphoma, breast cancer, leukemia and lung cancer.
The medicine prepared by the embodiment of the invention can effectively treat vomit in the tumor process, does not influence the treatment, can be taken while treating, can effectively inhibit the proliferation of tumor cells by wrapping the tumor cells after the oil on the loach epidermis enters the body, and can be used for insisting on drinking for 6 months after the tumor is removed by matching with an operation.
The invention can help the patients with advanced tumor to improve symptoms, relieve pain and improve the survival quality of the patients. Can also achieve the effect of prolonging the life of the patient and even possibly survival with tumor.
The medicine can be used for treating tumors such as gastric cancer, gastritis, rectal cancer, lymphoma, breast cancer, leukemia, lung cancer and the like, and has a remarkable curative effect. The invention has relatively low treatment cost which is far lower than that of western medicine and has obvious treatment effect.
The invention has the advantages of easily obtained raw materials, simple process, low cost and high efficiency, and is beneficial to pharmaceutical enterprises to carry out drug production and quality control; the product has low price and is easy to be accepted by patients.
1. And (3) clinical trials:
clinical data: the total number of patients participating in the clinical trial was 60, 18 men and 12 women in the chemotherapy group (control group); mean age (66.1 ± 7.82) years; 13 cases in III stage, and 17 cases in IV stage. The medicated diet is prepared into 20 male cases and 10 female cases; the mean age (64.87 + -8.86 years; 14 cases in stage III, 16 cases in stage IV.) the comparison of the baseline data in age, sex, weight, KPS score, TNM stage, etc. for both groups of patients was not statistically significant (P > 0.05) and was comparable.
2. The clinical test method comprises the following steps:
the standard-compliant cases were included in the chemotherapy groups (control group) and experimental groups, 30 cases each, using a contemporary control, non-randomized clinical study approach. The control group adopts oxaliplatin and tegafur with oxaliplatin (Jiangsu Henrie medicine GmbH, specification: 20mg, national Standard: H20000337)135mg/m2d1+ tegafur (Qilu pharmaceutical Co., Ltd., specification: 20mg, national standard of medicine: H20100150), and has a body surface area of less than 1m240 mg; 1 to 1.5m250 mg; greater than 1.5m260mg, 2 times daily to 14 days. Repeat to 21d for 2 courses. The experimental group orally takes the decoction obtained in the embodiment of the invention on the basis of a control group, the decoction is respectively taken 1 time in the morning and evening, each time is 400-500mL, 21d is 1 period, and two groups of patients are treated for half a year. 6 cycles of cases after radical operation and 3-6 cycles of advanced cases.
3. Clinical efficacy evaluation criteria:
complete Remission (CR): all focus disappears and is maintained for more than 28 days;
partial Remission (PR): the sum of the length and the diameter of the focus is reduced by more than 30 percent and maintained for more than 28 days;
disease Stability (SD): between PR and PD;
progression (PD): the total length and diameter of the focus is increased by more than 20 percent, or a new focus appears;
clinical effective rate (RR) ═ CR + PR/total number of cases;
disease Control Rate (DCR) ═ CR + PR + SD)/total number of cases.
4. The clinical test results are as follows:
after four courses of treatment, the control group: CR is 0 case, PR is 9 cases, SD is 14 cases, clinical effective rate (RR) is 30.00%, and Disease Control Rate (DCR) is 76.67%; experimental groups: CR is 0 case, PR is 16 cases, SD is 12 cases, the clinical effective rate (RR) is 53.33%, the Disease Control Rate (DCR) is 93.33%, and the comparison difference of the two groups has statistical significance (P is less than 0.05). After four courses of treatment, the clinical effective rate and the disease control rate of the experimental group are better than those of the control group, and the specific test results are shown in table 1.
TABLE 1 therapeutic effect comparison table of clinical test of experimental group and control group
| Group of | Number of cases | CR | PR | SD | PD | RR | DCR |
| Control group | 30 | 0 | 9 | 14 | 7 | 30.00 | 76.67 |
| Experimental group | 30 | 0 | 16 | 12 | 2 | 53.33 | 93.33 |
Comparison with the control group: p < 0.05.
Typical cases
Hu, man, 71 years old, in the city of Zhi county Shi Zhi. The body is hard at ordinary times, the patient is examined in a county citizen hospital in 17 years due to unsmooth stool, and the late rectal cancer is concluded through clinical examination, X-ray examination, CT examination, ultrasonic examination, endoscope examination and final biopsy. By further inquiry, the doctor can recover the life cycle for 3-6 months by experiential politeness.
After the family members and patients are in business, the medical treatment such as radiotherapy, chemotherapy and the like is abandoned, the medicated diet obtained in the embodiment 1 is taken after the family members come home, and the use is stopped after 4 months. The affected part is removed by operation in 19 years of autumn admission. Whole body examination without tumor metastasis; the pathological part is removed, and the tumor exists. To date, there is no recurrence of tumor and no metastasis. The production and life are not affected by normal work in the period.
Wu, a man, aged 49 years now, who lives at county Shimen town, who is near-Yiyi city, has years of severe gastritis, takes the stomach medicine for a long time, adopts the medicated food obtained in the example 3 years ago, and after insisting on taking the medicated food obtained in the example for 21 days, the gastritis symptom disappears, and does not take any stomach medicine so far.
Zhang, women, 42 years old, Yuan-Yi City, Hedong, suffered from lymphoma in 13 years, examined in Beijing 309 Hospital, followed by chemotherapy while taking the formulation of example 1, during which the stomach only had slight to negligible reaction, no vomiting, no influence on food intake, and normal excretion. After the medicated diet obtained in example 1 is taken for half a year, the tumor relapse and tumor metastasis do not occur, the operation is normal, and the production and life are not influenced.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include such modifications and variations.
Claims (8)
1. The preparation method of the medicated food for treating the gastric cancer and the rectal cancer is characterized by comprising the following steps:
(1) taking 180g of wild loaches, scalding with 10-20 times of boiled water, and reserving the boiled water and mucus floating on the upper layer;
(2) taking out viscera of loach, adding into the boiled water, adding 1-5g of seasoning, boiling with strong fire, stewing with slow fire for 30-45min, decocting loach to be thoroughly cooked, decocting the final soup with 800 plus materials in 1000ml, taking out loach residue, and cooling the soup to obtain the loach soup.
2. The preparation method of the medicated diet for treating gastric cancer and rectal cancer as claimed in claim 1, wherein the seasonings comprise green Chinese onion, ginger, salt and vinegar.
3. The preparation method of the medicated diet for treating gastric cancer and rectal cancer as claimed in claim 1, wherein in step (2), traditional Chinese medicines comprising 10g of radix astragali and 15g of lily are added while seasonings are added.
4. The preparation method of the medicated diet for treating gastric cancer and rectal cancer as claimed in claim 3, wherein the Chinese medicinal herbs further comprise rhizoma Cyperi 1g and radix aucklandiae 1 g.
5. The method for preparing medicated diet for treating gastric cancer and rectal cancer as claimed in claim 1, wherein the decoction obtained in step (2) is administered in two times, each time in the morning and evening, each time 400 mL.
6. The method for preparing medicated diet for treating gastric cancer and rectal cancer as claimed in claim 1, wherein the decoction or the original formulation is purified and made into granules, capsules, tablets, pills, oral liquid or injectable injection.
7. A medicated diet for treating gastric cancer and rectal cancer is prepared by adopting the preparation method of the medicated diet for treating gastric cancer and rectal cancer.
8. The preparation method of the medicated diet for treating gastric cancer and rectal cancer as claimed in claim 1, wherein the application of the medicated diet for treating gastric cancer and rectal cancer in the process of treating gastric cancer, gastritis, rectal cancer, lymphoma, breast cancer, leukemia and lung cancer is provided.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110797506.XA CN113455652A (en) | 2021-07-14 | 2021-07-14 | Medicated food for treating gastric cancer and rectal cancer and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110797506.XA CN113455652A (en) | 2021-07-14 | 2021-07-14 | Medicated food for treating gastric cancer and rectal cancer and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113455652A true CN113455652A (en) | 2021-10-01 |
Family
ID=77880328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110797506.XA Pending CN113455652A (en) | 2021-07-14 | 2021-07-14 | Medicated food for treating gastric cancer and rectal cancer and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113455652A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005056029A1 (en) * | 2003-12-10 | 2005-06-23 | Shanghai Baike Pharmaceutical Co., Ltd. | The traditional chinese medicine preparation for treatment of tumour and method of making and using same |
| CN106266704A (en) * | 2016-09-13 | 2017-01-04 | 佛山市顺德区宝铜金属科技有限公司 | The Chinese medicine composition for the treatment of gastroenteritis and preparation method |
-
2021
- 2021-07-14 CN CN202110797506.XA patent/CN113455652A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005056029A1 (en) * | 2003-12-10 | 2005-06-23 | Shanghai Baike Pharmaceutical Co., Ltd. | The traditional chinese medicine preparation for treatment of tumour and method of making and using same |
| CN106266704A (en) * | 2016-09-13 | 2017-01-04 | 佛山市顺德区宝铜金属科技有限公司 | The Chinese medicine composition for the treatment of gastroenteritis and preparation method |
Non-Patent Citations (2)
| Title |
|---|
| 张晨晓: "泥鳅多糖的免疫调节和抗肿瘤作用的机理研究", 《有机化学》 * |
| 李秀才: "《饮食抗癌进行时》", 31 August 2011, 西安交通大学出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112656925A (en) | Medicinal and edible plant traditional Chinese medicine composition for preventing cancers | |
| CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
| CN103933450A (en) | Traditional Chinese medicine composition for preventing or/and treating gastrointestinal diseases and preparation method of composition | |
| CN103893611B (en) | A kind of medicine and preparation method who treats kidney stone | |
| WO2020042665A1 (en) | Shark cartilage glycoprotein and anticancer use thereof | |
| CN113455652A (en) | Medicated food for treating gastric cancer and rectal cancer and preparation method thereof | |
| CN103908616B (en) | The medicament of tumor remission patient radiotherapy side effect and preparation method | |
| CN106110292A (en) | A kind of Chinese and western medicinal composition for Ultrasonography radioprotective and preparation method | |
| CN111407872A (en) | Traditional Chinese medicine composition for treating liver cancer, medicine for treating liver cancer and preparation method of medicine | |
| CN1256976C (en) | Anti-cancer Chinese medicinal composition and its preparing method | |
| CN103893491B (en) | A kind of medicine and preparation method for the treatment of cyclomastopathy | |
| CN103735997B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of gastric cancer | |
| CN103550472B (en) | Health-protection prescription for cancer patient | |
| CN103735847B (en) | A kind of medicine and preparation method for the treatment of eczema | |
| CN105833228A (en) | Drug preparation for reversing gastric cancer drug resistance and application thereof | |
| CN117771334B (en) | Traditional Chinese medicine composition for regulating autophagy and resisting breast tumors and nodules as well as preparation method and application thereof | |
| CN107029177A (en) | Pollen Typhae decoction | |
| CN107260856A (en) | It is a kind of to treat Chinese medicine composition of hepatitis B and preparation method thereof | |
| CN104225340A (en) | Drug for treating leukaemia and preparation method | |
| CN105535799A (en) | Medicine for treating chronic cholecystitis and preparation method | |
| CN105617099A (en) | Medicine for treating adverse reactions caused by tumor chemotherapy and preparation method | |
| CN105477171A (en) | Capsule used for treating hyperlipemia and preparation method of capsule | |
| CN105287798A (en) | Lipid-lowering and slimming recovery pill | |
| CN111956761A (en) | Traditional Chinese medicine formula for increasing white blood cells and improving immunity, decocting method and eating method | |
| CN104189339A (en) | Health formula for patients with lung cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |